Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2025-12-24 @ 7:19 PM
NCT ID:
NCT01498003
Eligibility Criteria:
Inclusion Criteria:
* Age between 18y\~80y, with symptomatic coronary disease
* At least one lesion length more than 40mm to be treated by overlapping drug-eluting stents in major epicardial coronary vessel
Exclusion Criteria:
* Aspirin or clopidogrel intolerance
* Lesions length less than 40mm, or overlapping stent length less than 40mm
* Bifurcation lesions need to be treated by two stents
* Patients with acute coronary syndrome and elevated baseline cardiac enzyme (CK-MB)
* Left ventricular ejection fraction less than 0.35
* Baseline estimated GFR less than 30
* Estimated life time less than one year
* Refuse to sign the informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01498003
Study Brief:
Protocol Section:
NCT01498003